ArticleSA journal of radiology2025
Why? What? When? Utility of 4DCT in the preoperative imaging algorithm of primary hyperparathyroidism.
Article in SA journal of radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: 4-Dimensional computed tomography (4DCT) is a specialised examination used to locate diseased parathyroid glands in a confirmed case of primary hyperparathyroidism. Objectives: To define the role of 4DCT as a first-hand diagnostic tool in locating the abnormal parathyroid gland. Method: A retrospective cohort study of 44 patients with primary hyperparathyroidism was performed. Patients with preoperative 4DCT findings and surgical findings with histopathological results were included in the study to assess the effectiveness of 4DCT in locating the diseased parathyroid glands. Results: Of the 44 patients who underwent 4DCT, operative findings of three patients were discordant with the 4DCT findings. The calculated sensitivity of 4DCT was 93%. 4DCT was able to identify lesions in ectopic locations in two cases and missed one case in an intra-thyroidal location, misinterpreted as a suspicious thyroid lesion. The sensitivity of 4DCT in detecting multiglandular disease was 75%. Of the diagnosed parathyroid lesions, 52.1% were located on the left, 35.4% on the right and 12.5% were located bilaterally. Additionally, 76% were seen inferiorly and 24% were seen superiorly. Conclusion: 4DCT has high utility in the presurgical localisation of the eutopically or ectopically placed diseased parathyroid glands in single and multiglandular disease and also provides additional anatomical details. Contribution: 4DCT identified additional findings such as aberrant origin of right subclavian artery, which is an important pre-operative finding for the surgeon to be aware of. This study contributes to the existing literature on the role of 4DCT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.